La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
CurveBeam AI Croissance future
Future contrôle des critères 5/6
CurveBeam AI is forecast to grow earnings and revenue by 79.3% and 46.7% per annum respectively. EPS is expected to grow by 77.3% per annum. Return on equity is forecast to be -0.2% in 3 years.
Informations clés
79.3%
Taux de croissance des bénéfices
77.3%
Taux de croissance du BPA
Medical Equipment croissance des bénéfices | 16.0% |
Taux de croissance des recettes | 46.7% |
Rendement futur des capitaux propres | -0.2% |
Couverture par les analystes | Low |
Dernière mise à jour | 09 Jul 2024 |
Mises à jour récentes de la croissance future
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
6/30/2027 | 55 | 10 | N/A | 4 | 1 |
6/30/2026 | 41 | -3 | -5 | -5 | 2 |
6/30/2025 | 28 | -13 | -4 | -10 | 2 |
6/30/2024 | 11 | -23 | -19 | -19 | 2 |
12/31/2023 | 9 | -57 | -26 | -26 | N/A |
9/30/2023 | 9 | -54 | -24 | -24 | N/A |
6/30/2023 | 8 | -51 | -23 | -22 | N/A |
3/31/2023 | 5 | -33 | -18 | -17 | N/A |
12/31/2022 | 1 | -14 | -13 | -13 | N/A |
9/30/2022 | 1 | -11 | -11 | -11 | N/A |
6/30/2022 | N/A | -9 | -8 | -8 | N/A |
6/30/2021 | 1 | -3 | -2 | -2 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: CVB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Bénéfices vs marché: CVB is forecast to become profitable over the next 3 years, which is considered above average market growth.
Croissance élevée des bénéfices: CVB is expected to become profitable in the next 3 years.
Chiffre d'affaires vs marché: CVB's revenue (46.7% per year) is forecast to grow faster than the Australian market (5.4% per year).
Croissance élevée des revenus: CVB's revenue (46.7% per year) is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: CVB is forecast to be unprofitable in 3 years.